Free Trial

VectivBio (VECT) Competitors

VectivBio logo
$16.85 0.00 (0.00%)
As of 06/27/2025

VECT vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying VectivBio stock or one of its competitors? The main competitors of VectivBio include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

VectivBio vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and VectivBio (NASDAQ:VECT) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends.

180 Life Sciences has higher earnings, but lower revenue than VectivBio.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
VectivBio$27.34MN/A-$93.74MN/AN/A

In the previous week, 180 Life Sciences had 1 more articles in the media than VectivBio. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for VectivBio. 180 Life Sciences' average media sentiment score of 1.87 beat VectivBio's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Very Positive
VectivBio Neutral

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
VectivBio N/A N/A N/A

Summary

180 Life Sciences beats VectivBio on 2 of the 3 factors compared between the two stocks.

Get VectivBio News Delivered to You Automatically

Sign up to receive the latest news and ratings for VECT and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VECT vs. The Competition

MetricVectivBioMED IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.87B$5.52B$8.86B
Dividend YieldN/A2.70%5.36%4.13%
P/E RatioN/A21.1926.3919.77
Price / SalesN/A264.39408.83110.45
Price / CashN/A41.2925.8827.49
Price / BookN/A7.237.915.36
Net Income-$93.74M-$55.05M$3.15B$248.34M
7 Day PerformanceN/A-0.58%1.04%1.28%
1 Month PerformanceN/A6.50%5.36%5.45%
1 Year PerformanceN/A0.22%32.71%18.02%

VectivBio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VECT
VectivBio
N/A$16.85
flat
N/AN/A$0.00$27.34M0.0030High Trading Volume
ATNFW
180 Life Sciences
N/A$0.01
-1.2%
N/A-21.6%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.13
-21.0%
N/AN/A$0.00$106.21K0.0040News Coverage
Gap Up
ALVOW
Alvotech
N/A$1.73
+1.8%
N/A-43.1%$0.00$585.60M0.004Positive News
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
+6.5%
N/A-74.1%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.09
-1.1%
N/AN/A$0.00$38.00M0.0070Positive News
Gap Up
BTMDW
biote
N/A$0.02
-10.2%
N/A-97.9%$0.00$199.38M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.07
+13.4%
N/A-72.0%$0.00N/A0.008

Related Companies and Tools


This page (NASDAQ:VECT) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners